GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncoinvent A ONCIN.OL · NOK

Health Care · Oslo Børs · 🇳🇴 Norway

Compare

64.80

+3.51%

Close of 9 Nov 2026, in NOK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in NOK, from our data supplier.

FY2025

Revenue

NOK 28.1m

FY2016FY2025

Net income

−NOK 155.1m

FY2016FY2025

Free cash flow

−NOK 131.3m

FY2016FY2025

Shareholders' equity

NOK 146.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueNOK 28.1mNOK 848,000NOK 354,000NOK 389,000NOK 774,000NOK 601,000NOK 8.9mNOK 2.3m——
Gross profit—−NOK 2.6m−NOK 5.1m−NOK 5.7m——————
Research and developmentNOK 62.9mNOK 87.7mNOK 107.8mNOK 202.4mNOK 205.8m—NOK 21.2mNOK 10.3mNOK 12.5m—
Operating income−NOK 158.3m−NOK 151.2m−NOK 191.8m−NOK 305.6m−NOK 314.5m−NOK 261.1m−NOK 204.4m−NOK 194.5m−NOK 183.7m−NOK 131.6m
Net income−NOK 155.1m−NOK 139.3m−NOK 190.4m−NOK 302.1m−NOK 309.4m−NOK 257.0m−NOK 199.3m−NOK 191.7m−NOK 182.2m−NOK 129.8m
Diluted earnings per share-1.59-1.51-1.95-3.09-3.17-0.39-3.38-3.58-3.98-4.17

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsNOK 205.0mNOK 171.0mNOK 174.3mNOK 166.7mNOK 450.2mNOK 738.2mNOK 270.4mNOK 378.8mNOK 384.3mNOK 174.5m
Cash and short-term investmentsNOK 177.6mNOK 140.2mNOK 156.4mNOK 150.8m—NOK 721.6mNOK 253.6mNOK 360.4mNOK 370.4mNOK 161.8m
Total liabilitiesNOK 58.6mNOK 62.7mNOK 46.9mNOK 78.2mNOK 65.8mNOK 68.0mNOK 50.6mNOK 41.5mNOK 34.0mNOK 21.3m
DebtNOK 675,000NOK 818,000—NOK 275,000NOK 942,000NOK 2.0m————
Shareholders' equityNOK 146.3mNOK 108.3mNOK 127.5mNOK 88.5mNOK 384.4mNOK 670.2mNOK 219.8mNOK 337.3mNOK 350.4mNOK 153.3m
Shares outstanding98m92m98m98m98m653m59m54m46m31m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−NOK 131.2m−NOK 153.2m−NOK 138.1m−NOK 288.2m−NOK 303.3m−NOK 234.3m−NOK 186.7m−NOK 186.7m−NOK 168.1m−NOK 124.3m
Capital spending−NOK 119,000−NOK 1.8m−NOK 26.8m−NOK 4.0m—−NOK 67,000—−NOK 228,000−NOK 340,000−NOK 255,000
Free cash flow−NOK 131.3m−NOK 155.0m−NOK 164.9m−NOK 292.2m−NOK 303.3m−NOK 234.4m−NOK 186.7m−NOK 186.9m−NOK 168.4m−NOK 124.6m

Latest quarters

By quarter end

Jun 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023
RevenueNOK 4.7mNOK 681,000——NOK 167,000NOK 354,000——
Gross profit—NOK 1.7m——————
Operating income−NOK 54.6m−NOK 33.5m−NOK 27.2m−NOK 50.8m−NOK 39.8m−NOK 43.5m−NOK 28.1m−NOK 47.8m
Net income−NOK 54.1m−NOK 28.6m−NOK 24.8m−NOK 49.7m−NOK 36.1m−NOK 41.6m−NOK 27.9m−NOK 48.8m
Diluted earnings per share-0.55-0.31-0.27-0.54-1.34-1.57-0.01-0.15
Cash from operations−NOK 73.0m−NOK 153.0m−NOK 116.0m−NOK 46.0m————
Total assetsNOK 86.8mNOK 155.8mNOK 194.7mNOK 218.5mNOK 135.4mNOK 174.3mNOK 188.0mNOK 240.4m
Cash and short-term investmentsNOK 69.5mNOK 140.2mNOK 174.8m—NOK 117.3mNOK 156.4mNOK 169.3mNOK 226.0m
Debt—NOK 818,000————NOK 101,000—
Shareholders' equityNOK 67.0mNOK 122.7mNOK 153.4mNOK 175.3mNOK 93.3mNOK 127.5mNOK 161.2mNOK 188.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue316.3%115.7%—
Operating income-19.7%-9.5%8.1%
Net income-19.9%-9.6%8.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1070.5%-2720.9%-4454.9%—
Net margin-1017.9%-2653.0%-4360.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-29.2-44.1-116.3-189.8-503.3-6426.4-557.0-576.2-401.4
Price to sales161.2————————

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 19 Jan 2026
  • 100-to-1 reverse split · 30 May 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.